...
首页> 外文期刊>Pakistan journal of medical sciences. >Role of Vitamin D in reducing number of acute exacerbations in Chronic Obstructive Pulmonary Disease (COPD) patients
【24h】

Role of Vitamin D in reducing number of acute exacerbations in Chronic Obstructive Pulmonary Disease (COPD) patients

机译:维生素D在减少慢性阻塞性肺疾病(COPD)患者急性加重次数中的作用

获取原文
           

摘要

Background and Objective: Chronic obstructive pulmonary disease (COPD) is characterized by chronic incompletely reversible poor airflow and air trapping and usually this debilitating disorder limits the outside activities of the patients depriving them of sunlight which is a rich source of Vitamin D. The objective of this study was to determine the effect of vitamin D supplementation in reducing number of acute exacerbation in COPD patients.Methods: This randomized control trial was conducted at East Medical Ward Mayo Hospital Lahore from January to December 2015 as exacerbations of COPD are season dependent. Diagnosis was confirmed by performing Pulmonary Function Tests (PFTs). Basic demographical information was obtained and baseline PFTs of the patient was done. Only Group A patients was treated with oral vitamin D intake of 2000 IU daily for 6 months. Vitamin D level was measured at 0, 2, 4, and 6 months and exacerbation of COPD, FEV1 and FVC was measured weekly. Both the groups were given standard treatment for exacerbation of COPD. Spirometry was repeated at each visit. Blood samples were collected every 2 months for vitamin D. Supplementation was stopped if vitamin D level exceeded 100ng/ml.Results: The mean age of the patients was 46.28±8.83 years, the male to female ratio was 1.8:1. The mean 25(OH) level at baseline was 24.08±2.58 and at 6th month was 29.60±8.74. The mean FVC at baseline was 77.83±5.49 and at 6th month was 91.34±5.52. The exacerbation at baseline was present in all 120(100%) patients and at 6th month was reduced to 4(3.3%).Conclusion: Vitamin D supplementation has significant effect in reducing number of acute exacerbation in COPD patients when it is given for prolonged period.
机译:背景与目的:慢性阻塞性肺疾病(COPD)的特征是慢性不完全可逆的不良气流和空气滞留,通常这种使人衰弱的疾病限制了患者的外界活动,使他们失去了阳光,而阳光是维生素D的丰富来源。方法:这项随机对照试验于2015年1月至2015年12月在拉合尔东医疗区梅奥医院进行,因为慢性阻塞性肺病的加重与季节有关。通过执行肺功能测试(PFT)确认诊断。获得了基本的人口统计学信息,并完成了患者的基线PFT。仅A组患者接受每天2000 IU的口服维生素D摄入量治疗,持续6个月。分别在0、2、4和6个月测量维生素D水平,每周测量一次COPD,FEV1和FVC恶化情况。两组均接受了COPD急性加重的标准治疗。每次访视时重复肺活量测定。每2个月采集一次血液样本中的维生素D。如果维生素D水平超过100ng / ml,则停止补充。结果:患者的平均年龄为46.28±8.83岁,男女之比为1.8:1。基线时平均25(OH)水平为24.08±2.58,第六个月为29.60±8.74。基线时的平均FVC为77.83±5.49,第6个月时的平均FVC为91.34±5.52。所有120例(100%)患者均出现基线加重,第6个月减少至4例(3.3%)。结论:长期服用维生素D可显着减少COPD患者的急性加重次数期。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号